JPWO2020181102A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020181102A5 JPWO2020181102A5 JP2021548244A JP2021548244A JPWO2020181102A5 JP WO2020181102 A5 JPWO2020181102 A5 JP WO2020181102A5 JP 2021548244 A JP2021548244 A JP 2021548244A JP 2021548244 A JP2021548244 A JP 2021548244A JP WO2020181102 A5 JPWO2020181102 A5 JP WO2020181102A5
- Authority
- JP
- Japan
- Prior art keywords
- crispr
- activity
- cas effector
- polypeptide
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962815179P | 2019-03-07 | 2019-03-07 | |
| US62/815,179 | 2019-03-07 | ||
| PCT/US2020/021214 WO2020181102A1 (en) | 2019-03-07 | 2020-03-05 | Crispr-cas effector polypeptides and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022522650A JP2022522650A (ja) | 2022-04-20 |
| JPWO2020181102A5 true JPWO2020181102A5 (de) | 2023-03-13 |
Family
ID=72338076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021548244A Pending JP2022522650A (ja) | 2019-03-07 | 2020-03-05 | Ｃｒｉｓｐｒ－ｃａｓエフェクターポリペプチド及びその使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210380957A1 (de) |
| EP (1) | EP3935155A4 (de) |
| JP (1) | JP2022522650A (de) |
| CN (1) | CN114040971A (de) |
| WO (1) | WO2020181102A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10660419B2 (en) * | 2016-12-15 | 2020-05-26 | Elc Management Llc | Packaged skin treatment composition and method |
| US10947552B1 (en) | 2020-09-30 | 2021-03-16 | Alpine Roads, Inc. | Recombinant fusion proteins for producing milk proteins in plants |
| AU2021353004A1 (en) | 2020-09-30 | 2023-04-13 | Nobell Foods, Inc. | Recombinant milk proteins and food compositions comprising the same |
| US10894812B1 (en) | 2020-09-30 | 2021-01-19 | Alpine Roads, Inc. | Recombinant milk proteins |
| TW202313971A (zh) | 2021-06-01 | 2023-04-01 | 美商喬木生物技術公司 | 包含crispr核酸酶的基因編輯系統及其用途 |
| WO2024006824A2 (en) * | 2022-06-28 | 2024-01-04 | Mammoth Biosciences, Inc. | Effector proteins, compositions, systems and methods of use thereof |
| WO2024173645A1 (en) | 2023-02-15 | 2024-08-22 | Arbor Biotechnologies, Inc. | Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcript |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6605709B1 (en) * | 1999-04-09 | 2003-08-12 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Proteus mirabilis for diagnostics and therapeutics |
| US20040029129A1 (en) * | 2001-10-25 | 2004-02-12 | Liangsu Wang | Identification of essential genes in microorganisms |
| CN1871252A (zh) * | 2003-09-05 | 2006-11-29 | Gtc生物治疗学公司 | 在转基因哺乳动物奶中生产融合蛋白的方法 |
| AU2011325956B2 (en) * | 2010-11-12 | 2016-07-14 | The General Hospital Corporation | Polycomb-associated non-coding RNAs |
| US9790490B2 (en) * | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
| CN118374475A (zh) * | 2015-12-29 | 2024-07-23 | 孟山都技术公司 | 新型crispr相关转座酶及其用途 |
| EP3445856A1 (de) * | 2016-04-19 | 2019-02-27 | The Broad Institute Inc. | Neuartige crispr-enzyme und -systeme |
| WO2018213351A1 (en) * | 2017-05-16 | 2018-11-22 | The Regents Of The University Of California | Thermostable rna-guided endonucleases and methods of use thereof |
| GB201712733D0 (en) * | 2017-08-08 | 2017-09-20 | Snipr Tech Ltd | Methods & cells |
-
2020
- 2020-03-05 CN CN202080030261.1A patent/CN114040971A/zh active Pending
- 2020-03-05 JP JP2021548244A patent/JP2022522650A/ja active Pending
- 2020-03-05 WO PCT/US2020/021214 patent/WO2020181102A1/en active Application Filing
- 2020-03-05 EP EP20767083.7A patent/EP3935155A4/de active Pending
-
2021
- 2021-08-16 US US17/403,236 patent/US20210380957A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016316845B2 (en) | Engineered CRISPR-Cas9 nucleases | |
| US10093910B2 (en) | Engineered CRISPR-Cas9 nucleases | |
| JP7210029B2 (ja) | ＣＲＩＳＰＲ－Ｃａｓ９の阻害因子 | |
| JP6940117B2 (ja) | オンターゲットおよびオフターゲットの多標的システムを用いた標的特異的ヌクレアーゼをスクリーニングするための方法およびその利用 | |
| US10767193B2 (en) | Engineered CAS9 systems for eukaryotic genome modification | |
| JP2023153907A (ja) | Ｒｎａ標的化方法および組成物 | |
| US10822606B2 (en) | Optimized small guide RNAs and methods of use | |
| JP2017018125A5 (de) | ||
| CN116732004A (zh) | CRISPR-Cas效应子多肽和其使用方法 | |
| JP2021121205A5 (de) | ||
| JP2015503535A5 (de) | ||
| RU2020105703A (ru) | Специфические для мишени варианты, связанные с crispr | |
| JP2022529329A (ja) | 人工的に構築されたｒｎａ編集酵素による部位特異的ｒｎａ編集および関連使用 | |
| AR125191A1 (es) | Enzimas modificadoras del adn y sus fragmentos activos y variantes y métodos de uso | |
| JPWO2020181102A5 (de) | ||
| JPWO2022056254A5 (de) | ||
| JP7249620B2 (ja) | 核酸結合因子 | |
| WO2023207607A1 (zh) | 用于修饰线粒体dna的脱氨酶突变体、组合物和方法 | |
| JP6874996B2 (ja) | 人工ｒｎａ制限酵素 | |
| US20240254464A1 (en) | Cleavage-inactive cas12f1, cleavage-inactive cas12f1-based fusion protein, crispr gene-editing system comprising same, and preparation method and use thereof | |
| JPWO2021007563A5 (de) | ||
| WO2022187278A1 (en) | Nucleic acid detection and analysis systems | |
| AR123483A1 (es) | Enzimas modificadoras de adn y fragmentos activos y variantes de las mismas y métodos de uso | |
| WO2023057880A1 (en) | Crispr/cas9-based fusion proteins for modulating gene expression and methods of use | |
| WO2024044717A1 (en) | Programmable rna writing using crispr effectors and trans-splicing templates |